Cell-derived Apolipoprotein E (ApoE) Particles Inhibit Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression in Human Endothelial Cells

Anita K. Stannard(The Royal Free Hospital), James S. Owen(The Royal Free Hospital), Claus Langer(Center for HIV and Hepatogastroenterology), Arnold von Eckardstein(University Hospital of Zurich), Takis Athanasopoulos(University of Wolverhampton), Paul Cullen(University of Münster), Sandra Sacre(The Royal Free Hospital), Aristides D. Tagalakis(Edge Hill University), George Dickson(Royal Holloway University of London), David Riddell(Eli Lilly (United States))
Journal of Biological Chemistry
December 1, 2001
10.1074/jbc.m104812200
Cited by 100

Related Papers

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
|European Heart Journal|2016|830
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351